Sarepta Therapeutics logo
Sarepta Therapeutics SRPT
€ 113.67 0.36%

Quartalsbericht 2024-Q2
hinzugefügt 07.08.2024

report update icon

Sarepta Therapeutics Kennzahlen 2011-2024 | SRPT

Kennzahlen Jährlich Sarepta Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-23.8 -15.1 -14.9 -12.2 -12.1 -23.8 -75.1 -5.3 -2.3 -3.5 -7.6 -5.3 -50.3

P/S

10.3 11.4 8.9 12.6 22.8 28.6 24.6 260.2 401.0 49.2 59.5 17.2 2.5

EPS

-5.8 -8.0 -5.2 -7.1 -9.7 -5.5 -0.9 -5.5 -5.2 -3.4 -3.3 -5.1 -0.0

EV (Enterprise Value)

14.8 B 12.4 B 6.33 B 7.51 B 8.84 B 8.85 B 3.73 B 1.38 B 506 M 454 M 634 M 534 M 100 M

EBITDA per Share

-2.42 -5.65 -5.19 -6.89 -7.08 -5.21 -2.37 -5.31 -5.08 -3.25 -2.63 -1.19 -1.6

EV/EBITDA

-14.9 -11.6 -16.3 -25.1 -26.1 -5.0 -2.1 -3.2 -6.6 -16.1 -2.3

PEG

3.0 -0.55 -1.02 -0.6 0.16 0.04 -0.89 0.95 0.04 1.46 -0.21 0.0 -0.54

P/B

14.9 27.6 6.7 8.9 10.6 8.3 4.8 4.2 2.6 1.9 3.4 5.2 3.8

P/CF

-25.5 -32.7 -14.0 63.2 -16.7 -19.0 -15.0 -5.6 -3.3 -3.1 -12.4 -20.8 -4.5

ROE %

-62.37 -182.75 -45.13 -72.74 -87.40 -35.06 -6.42 -79.38 -115.59 -54.83 -45.30 -98.07 -7.47

ROA %

-16.42 -22.49 -13.30 -18.57 -39.23 -22.04 -3.88 -63.02 -80.37 -46.03 -38.41 -59.17 -4.26

ROCE %

-31.17 -139.29 -49.54 -74.06 -33.52 -23.55 -11.51 -75.77 -104.11 -51.82 -35.32 -23.55 -106.40

Current Ratio

1.4 1.1 1.4 1.3 5.5 8.2 13.9 5.0 3.6 6.7 7.5 2.5 2.2

DSO

90.3 71.9 66.1 65.0 90.0 59.5 69.6 352.0 1158.5 90.4 90.6 46.1 28.2

DIO

- - - - 1105.5 1339.1 4150.1 35975.0 - - - - -

DPO

- - - - 439.2 361.1 420.3 83360.4 - - - - -

Betriebszyklus

90.3 71.9 66.1 65.0 1195.5 1398.6 4219.7 36327.0 - - - - -

Finanzkreislauf

90.3 71.9 66.1 65.0 756.3 1037.4 3799.4 -47033.4 - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Sarepta Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.07 0.38 - -0.46 -0.27 -5.86 - -2.94 -2.65 -1.2 - -0.6 -1.02 -2.1 -2.4 -2.5 -1.93 -0.23 -3.16 -1.7 -3.74 -1.07 -2.05 -1.15 -1.67 -0.55 -0.37 -0.78 -1.15 1.53 -1.62 -1.18 -1.35 -1.31 -1.44 -1.25 -1.01 -1.49 -1.08 -0.71 -0.85 -0.75 -0.23 -1.24 -0.6 -1.32 -2.36 -2.17 0.36 -0.78 -0.06 -0.18 0.06 0.02

EBITDA per Share

- 0.46 - -0.23 -1.5 -1.44 - -1.5 -2.41 -0.87 - -82.5 -2.1 -1.8 K -2.16 K -1.5 K -1.61 -1.46 -3.09 K -1.43 -3.57 -1 -2.03 K -0.93 -1.5 -0.44 -0.36 -0.65 -1.09 -0.69 -1.62 -1.09 -1.28 -1.28 -1.44 -1.15 -0.96 -1.47 -1.08 -0.76 -0.72 -0.65 -0.87 -0.71 -0.51 -0.47 -0.39 -0.25 -0.21 -0.29 -0.4 -0.46 -0.43 -0.28

ROE %

-6.35 -10.18 -81.09 -140.91 -195.38 -224.01 -103.94 -114.20 -64.63 -49.54 -58.27 -83.12 -98.66 -101.68 -72.74 -76.70 -66.34 -80.33 -87.40 -72.24 -64.20 -41.00 -35.06 -24.45 -23.10 -20.50 -6.42 -29.65 -40.46 -50.97 -79.38 -87.09 -97.52 -101.01 -115.59 -99.55 -84.06 -75.75 -54.83 -40.46 -45.67 -39.69 -45.30 -91.92 -114.98 -100.78 -98.07 -52.43 -25.32 -27.70 -7.47 -12.96 4.12 5.91

ROA %

-1.32 -2.28 -18.97 -27.14 -33.99 -36.66 -15.04 -16.85 -7.05 -10.00 -10.81 -17.15 -21.93 -24.03 -18.57 -25.15 -25.50 -35.61 -39.23 -34.88 -32.60 -24.09 -22.04 -15.29 -14.29 -12.46 -3.88 -22.90 -32.63 -42.50 -63.02 -65.79 -71.38 -71.98 -80.37 -71.80 -62.73 -58.93 -46.03 -34.00 -38.50 -33.56 -38.41 -65.66 -75.42 -64.96 -59.17 -31.48 -14.70 -16.27 -4.26 -7.39 2.35 3.37

ROCE %

- - - -30.49 -60.98 -90.04 -69.69 -77.03 -53.88 -59.36 -70.24 -92.66 -103.31 -86.93 -74.06 -79.79 -76.90 -92.39 -86.23 -71.60 -63.28 -39.65 -33.29 -22.72 -21.75 -19.75 -21.75 -45.07 -56.04 -66.46 -79.22 -86.83 -97.23 -100.91 -115.68 -99.87 -86.28 -76.38 -54.02 -49.25 -45.55 -40.22 -36.29 -31.33 -26.99 -24.56 -23.87 -43.65 -73.32 -100.48 -112.24 -35.21 -31.63 -17.28

Current Ratio

1.5 1.4 1.4 1.3 1.3 1.3 1.1 1.2 - 1.4 1.4 1.2 1.2 1.2 1.3 1.3 1.3 1.3 1.8 1.8 1.8 1.8 2.7 2.7 2.7 2.7 2.5 2.5 2.5 2.5 4.8 4.8 4.8 4.8 3.3 3.3 3.3 3.3 6.2 6.2 6.2 6.2 6.6 6.6 6.6 6.6 2.5 2.5 2.5 2.5 - - - -

DSO

92.9 86.0 - 76.4 80.5 78.9 - 39.9 34.8 71.7 - 66.8 68.3 68.2 63.7 64.2 67.3 77.2 82.8 83.7 87.6 73.4 53.0 57.0 60.9 55.5 47.0 58.5 76.8 96.9 88.0 - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

92.9 86.0 - 76.4 80.5 78.9 - 39.9 34.8 71.7 - 66.8 68.3 68.2 63.7 64.2 67.3 77.2 82.8 83.7 87.6 73.4 53.0 57.0 60.9 55.5 47.0 58.5 76.8 96.9 88.0 - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

92.9 86.0 - 76.4 80.5 78.9 - 39.9 34.8 71.7 - 66.8 68.3 68.2 63.7 64.2 67.3 77.2 82.8 83.7 87.6 73.4 53.0 57.0 60.9 55.5 47.0 58.5 76.8 96.9 88.0 - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung